Amblyopia Treatment Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 72.5 Million |
| Market Size (2029) | USD 87.70 Million |
| CAGR (2024 - 2029) | 3.90 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Amblyopia Treatment Market Analysis
The Global Amblyopia Treatment Market size is estimated at USD 72.5 million in 2024, and is expected to reach USD 87.70 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).
The rising prevalence of amblyopia is expected to drive the market studied over the forecast period. According to an article published in Frontiers in Pediatrics in May 2022, amblyopia was recognized as a common vision disorder among children. It is a condition where children might suffer from decreased vision due to abnormal development of the visual cortex in infancy or childhood. It is usually unilateral and is the most common cause of vision loss and mononuclear blindness in children. The reported incidence of amblyopia was 1–5% worldwide in 2022.
According to the same source mentioned above, the pooled prevalence of amblyopia varied from 0.51% in Africa to 3.67% in Europe in 2022. In addition, as per an article published in BMC Pediatrics, amblyopia is one of the leading causes of visual impairment in preschool children in China. The prevalence of amblyopia in Asia was around 1.09% in 2022. Hence, the high prevalence of amblyopia is expected to drive the demand for amblyopia treatment products such as eye patches, atropine drops, glasses, and video games, which may ultimately drive the market studied over the forecast period.
The increasing technological advancements for the treatment of amblyopia are also expected to drive the growth of the market studied over the forecast period. For instance, in October 2023, NovaSight, a pediatric vision care company, received the US Food and Drug Administration clearance for CureSight, an amblyopia lazy eye treatment device.
Thus, the rising prevalence of amblyopia and increasing technological advancements are expected to drive the growth of the market studied over the forecast period. However, the lack of awareness about amblyopia conditions and the stringent regulatory framework are expected to restrain the market growth over the forecast period.
Amblyopia Treatment Market Trends
The Strabismic Amblyopia Segment is Expected to Hold a Significant Market Share in the Amblyopia Treatment Market
Strabismus, a condition where the eyes do not align properly, is a risk factor for the development of amblyopia. In this condition, the brain tends to ignore the image from the misaligned eye to avoid double vision, which can further inhibit the visual development of the affected eye.
According to an article published in Investigative Ophthalmology and Visual Science in June 2022, strabismus and amblyopia occur in approximately 3% of children by age three in the United States. Similarly, according to an article published in Taylor and Francis Online in December 2022, the overall prevalence of strabismus in Africa was estimated to be 0.8%.
Moreover, according to an article published in Medicina in January 2024, in children younger than three, 80% of cases of amblyopia were majorly due to strabismus. Hence, the prevalence of strabismus in various parts of the world is expected to drive the segment revenue over the forecast period.
Furthermore, the increasing research and development activities regarding strabismus are also expected to drive market growth. For instance, according to a clinical trial conducted at Boston Children's Hospital in September 2023, a small open-label clinical trial of donepezil raised hope for restoring some lost vision in older children and even adults with amblyopia that developed due to strabismus.
Thus, the rising prevalence of strabismus and increasing research activities are expected to drive the segment revenue over the forecast period.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
North America holds a significant share of the market studied due to the high number of people suffering from amblyopia, the developed healthcare industry in the region, and the presence of advanced treatment options and rising product launches. The rising prevalence of amblyopia in North America is expected to drive the market studied over the forecast period. For instance, according to an article published in Frontiers in Pediatrics in May 2022, the prevalence rate of amblyopia in the United States was 2.41% in 2022. Similarly, according to an article published in JAMA Network in January 2024, around 3-5% of young children in schools in Canada were diagnosed with amblyopia. Hence, the high prevalence of amblyopia across North America is expected to drive the market studied over the forecast period.
Furthermore, the increasing investments in research and development of eye-related diseases are also expected to drive market growth. For instance, as per the updated data from the Centers for Disease Control and Prevention in May 2024, around USD 1,146 million was invested in eye diseases in 2023 compared to USD 1,097 million in 2022.
Hence, the increasing investments in eye diseases are expected to drive new product launches for the treatment of amblyopia, which may ultimately drive the growth of the market studied over the forecast period.
Amblyopia Treatment Industry Overview
The amblyopia treatment market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the key players in the market are 3M, Vivid Vision Inc., NovaSight, RevitalVision, and Hilco Vision.
Amblyopia Treatment Market Leaders
-
Krafty Eye Patches
-
3M
-
Vivid Vision, Inc.
-
NovaSight
-
RevitalVision
*Disclaimer: Major Players sorted in no particular order
Amblyopia Treatment Market News
October 2023: Bynocs, a company that offers lazy eye treatment therapies, launched a vision therapy software program (AmblyGo) to treat amblyopia in the form of tailored computer games. The patient plays the games with both eyes open while wearing special 3D anaglyph glasses (with different color lenses) for 30 minutes over 30 sessions.
January 2023: InnoJin Inc., Sumitomo Corporation, and ImaCreate Co. Ltd reported the signing of an agreement for the joint development of an app to treat children with amblyopia using virtual reality (VR).
Amblyopia Treatment Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definitions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Amblyopia
- 4.2.2 Increasing Technological Advancements for the Treatment of Amblyopia
-
4.3 Market Restraints
- 4.3.1 Lack of Awareness About Amblyopia Conditions
- 4.3.2 Stringent Regulatory Framework
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value – USD)
-
5.1 By Type
- 5.1.1 Strabismic Amblyopia
- 5.1.2 Refractive Ambylopia
- 5.1.3 Deprivation Amblyopia
-
5.2 By Treatment Products
- 5.2.1 Eye Patches
- 5.2.2 Atropine Drops
- 5.2.3 Glasses
- 5.2.4 Video Games
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Bausch and Lomb Incorporated
- 6.1.2 Acorn operating company LLC
- 6.1.3 Oculus Pharmaceuticals Ltd
- 6.1.4 Santen Pharmaceuticals Co. Ltd
- 6.1.5 Coopervision
- 6.1.6 Frensel prism and lens. Co
- 6.1.7 Hilco Vision
- 6.1.8 Good-Lite
- 6.1.9 Vivid Vision Inc
- 6.1.10 Krafty Eye patches
- 6.1.11 Hoya Vision Care
- 6.1.12 Orthopad USA
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAmblyopia Treatment Industry Segmentation
Amblyopia is the reduction of best-corrected visual acuity in one or both eyes, which cannot be attributed exclusively to abnormalities in the eye. Amblyopia develops during childhood and results in the interruption of normal critical visual pathway development.
The amblyopia treatment market is segmented by type, treatment products, and geography. By type, the market is segmented into strabismic amblyopia, refractive amblyopia, and deprivation amblyopia. By treatment, the market is segmented into eye patches, atropine drops, glasses, and video games. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers market size and forecast in terms of value (USD) for the above segments.
| By Type | Strabismic Amblyopia | |
| Refractive Ambylopia | ||
| Deprivation Amblyopia | ||
| By Treatment Products | Eye Patches | |
| Atropine Drops | ||
| Glasses | ||
| Video Games | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Amblyopia Treatment Market Research FAQs
How big is the Amblyopia Treatment Market?
The Amblyopia Treatment Market size is expected to reach USD 72.5 million in 2024 and grow at a CAGR of 3.9% to reach USD 87.70 million by 2029.
What is the current Amblyopia Treatment Market size?
In 2024, the Amblyopia Treatment Market size is expected to reach USD 72.5 million.
Who are the key players in Amblyopia Treatment Market?
Krafty Eye Patches, 3M, Vivid Vision, Inc., NovaSight and RevitalVision are the major companies operating in the Amblyopia Treatment Market.
Which is the fastest growing region in Amblyopia Treatment Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Amblyopia Treatment Market?
In 2024, the North America accounts for the largest market share in Amblyopia Treatment Market.
What years does this Amblyopia Treatment Market cover, and what was the market size in 2023?
In 2023, the Amblyopia Treatment Market size was estimated at USD 69.67 million. The report covers the Amblyopia Treatment Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Amblyopia Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Amblyopia Treatment Industry Report
Statistics for the 2024 Amblyopia Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Amblyopia Treatment analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
